301 studies found for:    autism spectrum disorders OR autism OR pervasive developmental disorders OR PDD OR Kanner's syndrome OR child mental disorders OR asperger syndrome OR autistic OR developmental disabilities | Open Studies | Exclude Unknown | NIH
Show Display Options
Rank Status Study
21 Not yet recruiting Collaborative Study Of Neurofeedback Training Of 6-18 Year Olds With Autism
Condition: Autism
Intervention: Behavioral: Neurofeedback training
22 Recruiting Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Condition: Pervasive Development Disorders
Interventions: Drug: methylphenidate;   Other: placebo;   Drug: extended-release guanfacine
23 Recruiting Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors
Condition: Autism Spectrum Disorders
Interventions: Drug: Placebo Nasal Spray;   Drug: Oxytocin Nasal Spray
24 Not yet recruiting Partnering With Autistic Adults to Improve Healthcare
Condition: Autism Spectrum Disorder
Intervention: Behavioral: Use of toolkit
25 Recruiting Pivotal Response Treatment Package for Young Children With Autism
Condition: Autism Spectrum Disorder (ASD)
Intervention: Behavioral: Pivotal Response Treatment Package (PRT-P)
26 Recruiting Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders
Condition: Pervasive Developmental Disorder
Intervention: Drug: aripiprazole
27 Recruiting The Role of Vasopressin in the Social Deficits of Autism
Condition: Autism Spectrum Disorders
Interventions: Drug: Vasopressin;   Drug: Placebo
28 Recruiting Parenting Your Young Child With Autism: A Web-Based Tutorial
Condition: Autistic Disorder
Intervention: Other: On LIne Parent Training Tutorial
29 Recruiting Schema, Emotion, and Behavior Therapy for Children
Condition: Autism Spectrum Disorder
Interventions: Behavioral: Individual Cognitive Behavioral Therapy;   Behavioral: Standard Community Treatment
30 Recruiting Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
Condition: Tuberous Sclerosis Complex
Intervention:
31 Recruiting A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC)
Conditions: Solid Tumor;   Anaplastic Thyroid Cancer
Interventions: Drug: Crolibulin;   Drug: Cisplatin
32 Recruiting Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Advanced Malignant Mesothelioma;   Epithelial Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatous Mesothelioma
Interventions: Drug: pemetrexed disodium;   Drug: cisplatin;   Drug: cediranib maleate;   Other: placebo
33 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Anesthesia;   Pain;   Reflux;   Nausea;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure)
Intervention: Drug: Ampicillin
34 Recruiting GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer
Conditions: Estrogen Receptor Negative Breast Cancer;   Human Epidermal Growth Factor 2 Negative Carcinoma of Breast;   Triple Negative Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer;   Triple-negative Breast Cancer
Interventions: Drug: cisplatin;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: dynamic contrast-enhanced MRI, diffusion-weighted MRI & chemical exchange saturation transfer MRI;   Drug: GDC -0941
35 Recruiting A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Conditions: Transitional Cell Carcinoma of Bladder;   Urethra Cancer;   Ureter Cancer;   Malignant Tumor of Renal Pelvis
Interventions: Drug: Cisplatin;   Drug: Gemcitabine;   Biological: ALT-801
36 Recruiting A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers
Conditions: Carcinoma Neuroendocrine;   Small Cell Lung Carcinoma;   Malignant Epithelial Neoplasms
Interventions: Drug: Belinostat;   Drug: Cisplatin;   Drug: Etoposide
37 Recruiting ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed By Surgery
Conditions: Acinar Cell Adenocarcinoma of the Pancreas;   Adenocarcinoma of the Gallbladder;   Adult Primary Cholangiocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Cholangiocarcinoma of the Gallbladder;   Duct Cell Adenocarcinoma of the Pancreas;   Localized Unresectable Adult Primary Liver Cancer;   Periampullary Adenocarcinoma;   Recurrent Adult Primary Liver Cancer;   Recurrent Gallbladder Cancer;   Recurrent Pancreatic Cancer;   Stage II Gallbladder Cancer;   Stage III Pancreatic Cancer;   Stage IIIA Gallbladder Cancer;   Stage IIIB Gallbladder Cancer;   Stage IV Pancreatic Cancer;   Stage IVA Gallbladder Cancer;   Stage IVB Gallbladder Cancer
Interventions: Drug: ADH-1;   Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Other: laboratory biomarker analysis
38 Recruiting Calcitriol, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Dietary Supplement: calcitriol;   Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Other: pharmacological study
39 Recruiting S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: Gemcitabine;   Drug: Cisplatin;   Drug: Methotrexate;   Drug: Vinblastine;   Drug: Doxorubicin;   Drug: Filgrastim
40 Not yet recruiting Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors
Conditions: Recurrent Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: buparlisib;   Drug: gemcitabine hydrochloride;   Drug: cisplatin;   Other: pharmacological study;   Other: laboratory biomarker analysis;   Other: questionnaire administration

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years